Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Resource management or managing resources?

A Bagust

    Health Services Management Research
    |October 6, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Claims of reduced patient costs in outpatient clinics are critically examined. Failure to account for case-mix differences invalidates reported efficiency gains, questioning clinical budgeting initiatives.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

    Health technology assessment (Winchester, England)·2015
    Same author

    Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

    Health technology assessment (Winchester, England)·2013
    Same author

    Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis.

    Health technology assessment (Winchester, England)·2011
    Same author

    Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

    Health technology assessment (Winchester, England)·2011
    Same author

    Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer.

    Health technology assessment (Winchester, England)·2010
    Same author

    Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.

    Health technology assessment (Winchester, England)·2010
    Same journal

    Thank you!

    Health services management research·2026
    Same journal

    Enhancing job satisfaction and reducing burnout among healthcare workers: The mediating role of psychological capital before and after a targeted training intervention.

    Health services management research·2026
    Same journal

    Global trends and emerging themes in digital human resource management in healthcare: A bibliometric analysis.

    Health services management research·2026
    Same journal

    Enhancing collaboration and communication within nursing teams: Insights from nurses to inform health service management.

    Health services management research·2026
    Same journal

    Why "health in all policies" matters: Insights from the EHMA 2025 conference.

    Health services management research·2026
    Same journal

    An exercise in the prioritization of patient experience dimensions: What is important and for whom? A resource allocation simulation.

    Health services management research·2026
    See all related articles

    Area of Science:

    • Health economics
    • Healthcare management
    • Clinical finance

    Background:

    • An outpatient clinic reported a 25% reduction in average cost per patient.
    • This claim was based on the collection and use of detailed patient costing data.

    Discussion:

    • The study critically analyzes the methodology used by Stilwell and Hamlyn.
    • It highlights the crucial omission of accounting for case-mix variations.
    • This oversight undermines the validity of the reported cost savings.

    Key Insights:

    • Apparent gains in resource efficiency are nullified when case-mix differences are not considered.
    • Detailed patient costings alone may not accurately reflect true efficiency improvements.
    • The findings challenge the effectiveness of current resource management strategies.

    Related Experiment Videos

    Outlook:

    • Further research is needed to develop robust methods for patient costing that account for case-mix.
    • Healthcare managers require reliable data to make informed decisions about resource allocation.
    • The study prompts a re-evaluation of Clinical Budgeting and Resource Management initiatives.